Search | IOVS | ARVO Journals

Showing 1 – 20 of 170

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Deep neural network by transfer learning for the analysis of guttae in the patients with Fuchs endothelial corneal dystrophy

Kaito Narimoto; Naoki Okumura; Shohei Yamada; Kengo Okamura; Ayaka Izumi; Theofilos Tourtas; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):817. doi:

ARVO Annual Meeting Abstract June 2021

Proteomic analysis of TCF4 knock-out corneal endothelial cells derived from the patients with Fuchs endothelial corneal dystrophy

Tatsuya Nakagawa; Naoki Okumura; Naoya Hanada; Prema Padmanabhan; Sailaja Elchuri; Amit Chatterjee; Narayanan Janakiraman; Gajanan Sathe; Vivek Ghose; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):827. doi:

ARVO Annual Meeting Abstract June 2020

Effect of CTG repeat expansion in TCF4 on the pathophysiology of Fuchs endothelial corneal dystrophy

Hinata Matsuo; Naoki Okumura; Yuya Komori; Ayumi Tokunaga; Genta Nakayama; Makiko Nakahara; Derek J Blake; Theofilos Tourtas; Ursula Schlötzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1186. doi:

ARVO Annual Meeting Abstract June 2020

Effective isolation and expansion of human limbal niche cells

Andreas Gießl; Naresh Polisetti; Shen Li; Friedrich E Kruse; Ursula Schlötzer-Schrehardt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1200. doi:

ARVO Annual Meeting Abstract June 2020

Agonistic β2-adrenergic receptor autoantibodies characterize the aqueous humor of patients with primary and secondary open-angle glaucoma

Bettina Hohberger; Max Wörn; Robert Lämmer; Martin Herrmann; Christian Y Mardin; Friedrich E Kruse; Rudolf Kunze; Gerd Wallukat

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1222. doi:

ARVO Annual Meeting Abstract July 2019

Functional implication of the pseudoexfoliation-associated rare variant p.Y407F at LOXL1

Daniel Berner; Ursula Hoja; Matthias Zenkel; Francesca Pasutto; Mei Chin Lee; Tin Aung; Chiea Chuen Khor; André Reis; Friedrich E Kruse; Ursula Schlotzer-Schrehardt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1612. doi:

ARVO Annual Meeting Abstract July 2019

Silencing of pro-apoptotic proteins as anti-apoptotic therapy for corneal endothelium

Thomas Armin Fuchsluger; Daniel Thieme; Friedrich E Kruse; Siddharth Mahajan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2164. doi:

ARVO Annual Meeting Abstract July 2019

Potential functional restoration of corneal endothelial cells in Fuchs corneal dystrophy by ROCK inhibitor (Ripasudil)

Friedrich E Kruse; Theofilos Tourtas; Matthias Zenkel; Shigeru Kinoshita; Ursula Schlotzer-Schrehardt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2172. doi:

ARVO Annual Meeting Abstract July 2019

Involvement of a disintegrin and metalloproteinase 10 (ADAM10) in excessive extracellular matrix production in Fuchs endothelial corneal dystrophy

Yuya Komori; Naoki Okumura; Naoya Hanada; Ayumi Tokunaga; Theofilos Tourtas; Ursula Schlotzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2175. doi:

ARVO Annual Meeting Abstract July 2019

Involvement of caspase 7 in the excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy

Shigehito Tonomura; Naoki Okumura; Mako Endo; Makiko Nakahara; Theofilos Tourtas; Ursula Schlotzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2176. doi:

ARVO Annual Meeting Abstract July 2019

Drug discovery for the treatment of Fuchs corneal endothelial dystrophy by cell-based drug screening system

Risako Nakagawa; Naoki Okumura; Takako Onishi; Takeshi Oshima; Emi Ueda; Kyoko Watanabe; Theofilos Tourtas; Ursula Schlotzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3877. doi:

ARVO Annual Meeting Abstract July 2019

Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy

Genta Nakayama; Naoki Okumura; Takeshi Oshima; Emi Ueda; Kyoko Watanabe; Theofilos Tourtas; Ursula Schlotzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3878. doi:

ARVO Annual Meeting Abstract July 2019

Extracellular matrix regulation of limbal epithelial stem cell function

Ursula Schlotzer-Schrehardt; Franziska Kruse; Kerstin Kraus; Matthias Zenkel; Friedrich E Kruse

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4122. doi:

ARVO Annual Meeting Abstract July 2019

A potential role for impaired retinoic acid signaling in the pathophysiology of pseudoexfoliation syndrome/glaucoma

Matthias Zenkel; Daniel Berner; Ursula Hoja; Francesca Pasutto; Friedrich E Kruse; Ursula Schlotzer-Schrehardt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5666. doi:

ARVO Annual Meeting Abstract July 2019

Delayed corneal clearance after uneventful Descemet Membrane endothelial keratoplasty

Victor A Augustin; Julia M Weller; Friedrich E Kruse; Theofilos Tourtas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6285. doi:

ARVO Annual Meeting Abstract July 2019

Deturgescence using dextran negatively affects corneal endothelial cell viability of pre-stripped grafts for Descemet’s Membrane Endothelial Keratoplasty

Johannes Menzel-Severing; Gerd Geerling; Friedrich E Kruse; Peter Walter; Sabine Salla

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6290. doi:

ARVO Annual Meeting Abstract July 2019

Supplementation of amphotericin B in Optisol-GS for Descemet membrane endothelial keratoplasty (DMEK)

Maria Elena Galimi; Julia M Weller; Friedrich E Kruse; Victor A Augustin; Theofilos Tourtas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6300. doi:

ARVO Annual Meeting Abstract July 2018

Influence of Fuchs endothelial corneal dystrophy on contrast sensitivity in cataract patients

Theofilos Tourtas; Victor A Augustin; Julia Weller; Friedrich E Kruse

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1311. doi:

ARVO Annual Meeting Abstract July 2018

Can we optimize the refractive target in triple Descemet membrane endothelial keratoplasty in the fellow eye after surgery in the first eye?

Victor A Augustin; Julia Weller; Friedrich E Kruse; Theofilos Tourtas

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1326. doi:

ARVO Annual Meeting Abstract July 2018

Association of rs613872 and trinucleotide repeat expansion in the TCF4 gene in Fuchs endothelial corneal dystrophy in Germany

Yuya Komori; Naoki Okumura; Ryosuke Hayashi; Masakazu Nakano; Kei Tashiro; Kengo Yoshii; Ross Aleff; Malinda Butz; Edward W. Highsmith; Eric Wieben; Michael P. Fautsch; Keith H Baratz; Theofilos Tourtas; Ursula Schlotzer-Schrehardt; Friedrich E Kruse; Noriko Koizumi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1353. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Deep neural network by transfer learning for the analysis of guttae in the patients with Fuchs endothelial corneal dystrophy

Proteomic analysis of TCF4 knock-out corneal endothelial cells derived from the patients with Fuchs endothelial corneal dystrophy

Effect of CTG repeat expansion in TCF4 on the pathophysiology of Fuchs endothelial corneal dystrophy

Effective isolation and expansion of human limbal niche cells

Agonistic β2-adrenergic receptor autoantibodies characterize the aqueous humor of patients with primary and secondary open-angle glaucoma

Functional implication of the pseudoexfoliation-associated rare variant p.Y407F at LOXL1

Silencing of pro-apoptotic proteins as anti-apoptotic therapy for corneal endothelium

Potential functional restoration of corneal endothelial cells in Fuchs corneal dystrophy by ROCK inhibitor (Ripasudil)

Involvement of a disintegrin and metalloproteinase 10 (ADAM10) in excessive extracellular matrix production in Fuchs endothelial corneal dystrophy

Involvement of caspase 7 in the excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy

Drug discovery for the treatment of Fuchs corneal endothelial dystrophy by cell-based drug screening system

Feasibility of mTOR inhibitor for the treatment of Fuchs endothelial corneal dystrophy

Extracellular matrix regulation of limbal epithelial stem cell function

A potential role for impaired retinoic acid signaling in the pathophysiology of pseudoexfoliation syndrome/glaucoma

Delayed corneal clearance after uneventful Descemet Membrane endothelial keratoplasty

Deturgescence using dextran negatively affects corneal endothelial cell viability of pre-stripped grafts for Descemet’s Membrane Endothelial Keratoplasty

Supplementation of amphotericin B in Optisol-GS for Descemet membrane endothelial keratoplasty (DMEK)

Influence of Fuchs endothelial corneal dystrophy on contrast sensitivity in cataract patients

Can we optimize the refractive target in triple Descemet membrane endothelial keratoplasty in the fellow eye after surgery in the first eye?

Association of rs613872 and trinucleotide repeat expansion in the TCF4 gene in Fuchs endothelial corneal dystrophy in Germany

To View More...

You must be signed into an individual account to use this feature.